of those who use cannabis for cancer/treatment-related symptoms do so without clinical guidance.
of unguided, regular cannabis users will develop a cannabis use disorder or cannabis hyperemesis syndrome.
of employers surveyed would provide cannabis support for those with a critical illness.
Get your personalized, cost-saving projection for your organization when implementing a medicinal cannabis benefit for plan members. Typically ranging from 3% to 6%...
The purpose of the survey was to assess how many people are using cannabis now, why people are using cannabis, whether people would...
Fully and securely experience our customizable cannabis guidance and care offerings for employers including personalized care plans for employees dealing with cancer, sleep disorders, chronic pain...
In the quest for relief from the burdens of cancer treatment, individuals often turn to cannabis, seeking answers amidst the chaos of symptoms.
Recently, the Department of Health and Human Services recommended that cannabis be reclassified from a Schedule I Controlled Substance to a Schedule III Controlled Substance under the federal Controlled Substances Act. In a PM360 article Rescheduling Cannabis to a Schedule III Controlled Substance: A Regulator’s Perspective,
As more states legalize the use of cannabis, it can be challenging for employers to keep up and find reliable information. A recent Benefits Pro article, Employees are more likely to apply for jobs that offer cannabis benefits, shares findings from an EO Care ...
Get special offers, event invites and the latest on new care offerings and product releases.
